Literature DB >> 30206006

Health risk perceptions and reasons for use of tobacco products among clients in addictions treatment.

Barbara K Campbell1, Thao Le2, Noah R Gubner3, Joseph Guydish4.   

Abstract

INTRODUCTION: We examined rates of use, health risk perceptions and reasons for use of combustible and non-combustible tobacco products among clients enrolled in addictions treatment across the United States.
METHODS: Participants (N = 1153) completed tobacco use surveys and rated health risk perception of all products. Users of non-cigarette products reported their main reason for use of each product. Logistic regression analyses examined associations between health risk perceptions and product use, including combustible cigarette use, and between reasons for use and non-cigarette product use.
RESULTS: Cigarette smoking was reported by 77.5%, followed by use of e-cigarettes (26.6%), little filtered cigars (LFCs)/cigarillos (15.4%), smokeless tobacco (11.4%), and cigars (8.4%). Lower perceived health risk of cigarettes was associated with smoking cigarettes (OR = 0.985, 95% CI: 0.975-0.995, p = 0.005). Lower perceived health risk of e-cigarettes was associated with e-cigarette use (OR = 0.991, 95% CI: 0.984-0.998, p = 0.023). Users of cigars and users of LFC/cigarillos (versus other product use) were more likely to report their main reason for use as "enjoying flavor/ taste", and smokeless tobacco users were more likely to report "at times when can't smoke" as their main reason for use compared with other reasons. E-cigarette users were more likely to report to "reduce/quit cigarettes" as their main reason for use as compared to all other reasons except "reduce health risk".
CONCLUSION: Treating smoking in addictions treatment should assess all tobacco product use, accuracy of health risk perceptions, and use of e-cigarettes to reduce/quit smoking, in order to promote cessation of combustible tobacco.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Addictions treatment; Health risk perception; Smoking; Tobacco products

Mesh:

Year:  2018        PMID: 30206006      PMCID: PMC6474775          DOI: 10.1016/j.addbeh.2018.08.037

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  42 in total

1.  Perceived risks and benefits of smoking: differences among adolescents with different smoking experiences and intentions.

Authors:  Bonnie L Halpern-Felsher; Michael Biehl; Rhonda Y Kropp; Mark L Rubinstein
Journal:  Prev Med       Date:  2004-09       Impact factor: 4.018

2.  The Most Natural Tobacco Used: A Qualitative Investigation of Young Adult Smokers' Risk Perceptions of Flavored Little Cigars and Cigarillos.

Authors:  Kymberle L Sterling; Craig S Fryer; Pebbles Fagan
Journal:  Nicotine Tob Res       Date:  2015-07-14       Impact factor: 4.244

3.  Perception of e-cigarette harm and its correlation with use among U.S. adolescents.

Authors:  Stephen M Amrock; Joseph Zakhar; Sherry Zhou; Michael Weitzman
Journal:  Nicotine Tob Res       Date:  2014-08-14       Impact factor: 4.244

Review 4.  Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review.

Authors:  Konstantinos E Farsalinos; Riccardo Polosa
Journal:  Ther Adv Drug Saf       Date:  2014-04

5.  Tobacco industry use of flavours to recruit new users of little cigars and cigarillos.

Authors:  Ganna Kostygina; Stanton A Glantz; Pamela M Ling
Journal:  Tob Control       Date:  2014-10-29       Impact factor: 7.552

6.  Electronic cigarettes in adults in outpatient substance use treatment: Awareness, perceptions, use, and reasons for use.

Authors:  Erica N Peters; Paul T Harrell; Peter S Hendricks; Kevin E O'Grady; Wallace B Pickworth; Frank J Vocci
Journal:  Am J Addict       Date:  2015-03-24

7.  Use of multiple tobacco products in a national sample of persons enrolled in addiction treatment.

Authors:  Joseph Guydish; Barbara Tajima; Sowmya Pramod; Thao Le; Noah R Gubner; Barbara Campbell; Paul Roman
Journal:  Drug Alcohol Depend       Date:  2016-07-14       Impact factor: 4.492

8.  Patterns of Alternative Tobacco Product Use: Emergence of Hookah and E-cigarettes as Preferred Products Amongst Youth.

Authors:  Tamika D Gilreath; Adam Leventhal; Jessica L Barrington-Trimis; Jennifer B Unger; Tess Boley Cruz; Kiros Berhane; Jimi Huh; Robert Urman; Kejia Wang; Steve Howland; Mary Ann Pentz; Chih Ping Chou; Rob McConnell
Journal:  J Adolesc Health       Date:  2015-11-17       Impact factor: 5.012

9.  Smoking among patients in substance use disorders treatment: associations with tobacco advertising, anti-tobacco messages, and perceived health risks.

Authors:  Barbara K Campbell; Thao Le; K Blakely Andrews; Sowmya Pramod; Joseph Guydish
Journal:  Am J Drug Alcohol Abuse       Date:  2016-06-17       Impact factor: 3.829

10.  They're heating up: Internet search query trends reveal significant public interest in heat-not-burn tobacco products.

Authors:  Theodore L Caputi; Eric Leas; Mark Dredze; Joanna E Cohen; John W Ayers
Journal:  PLoS One       Date:  2017-10-11       Impact factor: 3.240

View more
  10 in total

1.  Smoking relapse risk is increased among individuals in recovery.

Authors:  Amanda J Quisenberry; Jami Pittman; Renee D Goodwin; Warren K Bickel; Giordano D'Urso; Christine E Sheffer
Journal:  Drug Alcohol Depend       Date:  2019-07-08       Impact factor: 4.492

2.  From tobacco-endgame strategizing to Red Queen's race: The case of non-combustible tobacco products.

Authors:  Karma McKelvey; Bonnie Halpern-Felsher
Journal:  Addict Behav       Date:  2019-01-08       Impact factor: 3.913

3.  Smoking-Related Health Beliefs in a Sample of Psychiatric Patients: Factors Associated with the Health Beliefs and Validation of the Health Belief Questionnaire.

Authors:  P V Asharani; Jue Hua Lau; Vanessa Ai Ling Seet; Fiona Devi; Peizhi Wang; Kumarasan Roystonn; Ying Ying Lee; Laxman Cetty; Wen Lin Teh; Swapna Verma; Yee Ming Mok; Siow Ann Chong; Mythily Subramaniam
Journal:  Int J Environ Res Public Health       Date:  2021-02-07       Impact factor: 3.390

4.  Nicotine and cannabis vaping among adolescents in treatment for substance use disorders.

Authors:  Kelly C Young-Wolff; Sara R Adams; Stacy A Sterling; Andy S L Tan; Ramzi G Salloum; Kira Torre; Lisa Carter-Harris; Judith J Prochaska
Journal:  J Subst Abuse Treat       Date:  2021-01-27

5.  Drug use disorder and risk of incident and fatal prostate cancer among Swedish men: a nationwide epidemiological study.

Authors:  Disa Dahlman; Xinjun Li; Casey Crump; Jan Sundquist; Kristina Sundquist
Journal:  Cancer Causes Control       Date:  2021-11-07       Impact factor: 2.506

6.  Youth Demographic Characteristics and Risk Perception of Using Alternative Tobacco Products: An Analysis of the 2014-2015 Canadian Student Tobacco, Alcohol, and Drugs Survey (CSTADS).

Authors:  Udoka Okpalauwaekwe; Chinenye Nmanma Nwoke; Jacinthe Messier
Journal:  Tob Use Insights       Date:  2021-11-22

7.  Healthcare utilization for somatic conditions among Swedish patients in opioid substitution treatment, with and without on-site primary healthcare.

Authors:  Teodor Vikbladh; Katja Troberg; Anders Håkansson; Disa Dahlman
Journal:  BMC Health Serv Res       Date:  2022-07-29       Impact factor: 2.908

8.  Factors associated with augmentation in patients with restless legs syndrome.

Authors:  Beatrice Heim; Philipp Ellmerer; Ambra Stefani; Melanie Bergmann; Elisabeth Brandauer; Klaus Seppi; Birgit Högl; Atbin Djamshidian
Journal:  Eur J Neurol       Date:  2021-12-29       Impact factor: 6.288

9.  Cigarette smokers' concurrent use of smokeless tobacco: dual use patterns and nicotine exposure.

Authors:  Nicholas J Felicione; Jenny E Ozga-Hess; Stuart G Ferguson; Geri Dino; Summer Kuhn; Ilana Haliwa; Melissa D Blank
Journal:  Tob Control       Date:  2020-02-12       Impact factor: 7.552

10.  Drug use disorder and risk of incident and fatal breast cancer: a nationwide epidemiological study.

Authors:  Disa Dahlman; Hedvig Magnusson; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Breast Cancer Res Treat       Date:  2020-11-06       Impact factor: 4.872

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.